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The two p160 transcriptional coregulator family
members SRC-1 and TIF2 have important metabolic
functions in white and brown adipose tissues as well
as in the liver. To analyze TIF2 cell-autonomous func-
tions in skeletal muscles, we generated TIF2(i)skm/
mice in which TIF2 was selectively ablated in skeletal
muscle myofibers at adulthood. We found that
increased mitochondrial uncoupling in skeletal
muscle myocytes protected these mice from
decreased muscle oxidative capacities induced by
sedentariness, delayed the development of type 2
diabetes, and attenuated high-caloric-diet-induced
obesity. Moreover, our results demonstrate that
SRC-1 and TIF2 can modulate the expression of the
uncoupling protein 3 (UCP3) in an antagonistic
manner and that enhanced SRC-1 levels in TIF2-defi-
cient myofibers are critically involved in the meta-
bolic changes of TIF2(i)skm/mice. Thus, modulation
of the expression and/or activity of these coregula-
tors represents an attractive way to prevent or treat
metabolic disorders.
INTRODUCTION
To maintain the body weight of adult mammals, caloric intake
has to be balanced by energy expenditure, resulting mainly
from physical activity and thermogenesis. In industrialized
countries, characterized by sedentary lifestyle and high-caloric
diet, this balance is often deregulated, leading to the develop-
ment of obesity, dyslipidemia, hyperglycemia, insulin resistance
(type 2 diabetes), and hypertension.
Metabolic homeostasis is regulated by complex transcrip-
tional signaling pathways in various tissues. The three members496 Cell Metabolism 12, 496–508, November 3, 2010 ª2010 Elsevierof the p160 transcriptional coregulators (the steroid receptor
coactivator 1 [SRC-1, also called NcoA-1], the transcriptional
intermediary factor 2 [TIF2, also referred as SRC-2, GRIP1, or
NCOA2], and steroid receptor co-activator 3 [SRC-3, also called
p/CIP, AIB1, ACTR, RAC3, or TRAM-1]) have been shown to
control energy balance. Indeed, SRC-1 null mice are prone to
obesity (Picard et al., 2002), whereas TIF2 null and SRC-3 null
mice are protected against diet-induced obesity (Coste et al.,
2008; Picard et al., 2002). It has been proposed that TIF2 plays
a predominant metabolic role in white adipose tissue by regu-
lating the activity of the peroxisome proliferator-activated
receptor (PPAR) g and in brown adipose tissue by modulating
the interaction between SRC-1 and PPARg coactivator-1a
(PGC-1a) (Picard et al., 2002). Moreover, TIF2 has been identi-
fied as a regulator of hepatic glucose release upon fasting by
controlling glucose-6-phosphatase expression in hepatocytes
(Chopra et al., 2008).
Skeletal muscles, which generate locomotor force and heat,
also play an important metabolic role in mammals. They are
composed of myofibers exhibiting distinct contractile and meta-
bolic properties and they display a remarkable adaptation to
functional and metabolic demands (Schiaffino, 2010). Sedentar-
iness induces a decrease of muscle oxidative capacities (Fig-
ueiredo et al., 2009), and muscle fiber type switching toward
lower oxidative capacity has been shown to promote obesity
and type 2 diabetes (Schuler et al., 2006). In contrast, endurance
exercise induces muscle fiber type switching from fast glycolytic
to slow oxidative (Handschin et al., 2007), while caloric restric-
tion retards age-related reduction of muscle oxidative capacity
(Aspnes et al., 1997; Baker et al., 2006).
All three p160 family members are expressed in skeletal
muscle (Coste et al., 2008; Picard et al., 2002), and it has
been shown that TIF2 potentiates differentiation of cultured
C2C12 myoblasts into myotubes through the enhancement of
myocyte enhancer factor (MEF)-2C-mediated transactivation
(Chen et al., 2000) even though it corepresses transcriptionmedi-
ated by the myogenic transactivator Myo-D (Wu et al., 2005).Inc.
Figure 1. Increased Energy Expenditure in TIF2(i)skm–/– Mice Fed a Regular Diet
(A) Body weight of control and TIF2(i)skm/ mice.
(B) Lean and fat content of 18- and 30-week-old control and TIF2(i)skm/ mice analyzed by DEXA scanning.
(C) Food intake in 11-, 14-, and 30-week-old control and TIF2(i)skm/ mice.
(D) VO2 and VCO2 determined in 18- and 30-week-old control and TIF2
(i)skm/ mice.
(E and F) Evaluation of the RQ in 18- and 30-week-old control and TIF2(i)skm/ mice (E) and deduced heat production (F).
(G) Rectal temperature of 11-, 14-, and 30-week-old control and TIF2(i)skm/ mice.
(H) Oxygen consumption in saponin-skinned quadriceps fibers of 14- and 30-week-old control and TIF2(i)skm/ mice in the absence (V0) and presence (VMAX) of
ADP and evaluation of mitochondria uncoupling by the ACR.
(I) Relative transcript levels of UCP1, UPC2, and UPC3 in brown adipose tissue (BAT) of 30-week-old control and TIF2(i)skm/mice and in gastrocnemius muscle
of 11-, 14-, 18-, and 30-week-old control and TIF2(i)skm/ mice. Note that UCP1 transcripts were undetectable in gastrocnemius muscle.
(J) Representative western-blot analysis of UCP3, phospho-AMPK (pAMPK), total AMPK (AMPK), phospho-ACC (pACC), total ACC (ACC), phospho-4E-BP1
(p4E-BP1), and total 4E-BP1 (4E-BP1) in quadricepsmuscle of 14- and 30-week-old control and TIF2(i)skm/mice. Glyceraldehyde 3-phosphate dehydrogenase
(GAPDH) is used as an internal control.
(A–I) n = 10; error bars show SEM; *p < 0.05. (J) n = 6. See also Figure S1.
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Role of TIF2 and SRC-1 in Skeletal MusclesTo further investigate the function of TIF2 in skeletal
muscles, we have generated TIF2(i)skm/ mice in which TIF2
was selectively ablated in skeletal muscle myofibers at adult-
hood. Studies of thesemice have revealed that increased energy
expenditure was generated by SRC-1-dependent enhanced
skeletal muscle mitochondrial uncoupling. As a consequence,
sedentariness-induced adverse effects, such as reducedmuscle
oxidative capacities and type 2 diabetes, as well as high-caloric-
diet-induced obesity, were attenuated in TIF2(i)skm/ mice.
RESULTS
Energy Expenditure Is Increased in TIF2(i)skm–/– Mice
through Enhanced Skeletal Muscle Mitochondrial
Uncoupling
To investigate the impact of TIF2 ablation in skeletal muscle
myofibers on energy homeostasis, we generated TIF2(i)skm/Cell Mmice in which TIF2 is selectively ablated in mouse skeletal
muscle myofibers at adulthood (see Supplemental Results,
available online). When fed a chow diet, the body weight of
TIF2(i)skm/ mice was slightly lower than that of control mice
over a 30week period, but this difference did not reach statistical
significance (Figure 1A). Dual energy X-ray absortiometry (DEXA)
scan analyses did not reveal any difference in body lean and fat
contents between TIF2(i)skm/ and control mice at 18 and
30 weeks of age (Figure 1B). Moreover, skeletal muscle mass
and fiber size distribution, as well as epididymal adipose tissue
weight and adipocyte size, were similar in TIF2(i)skm/ and
control mice at 14 to 30 weeks of age (Figures S1A–S1F and
data not shown). However, food intake was 10% higher for
14- to 30-week-old TIF2(i)skm/ mice than for age-matched
control mice (Figure 1C), indicating that TIF2(i)skm/ mice
dissipate more energy. Even though the average voluntary
activities over a 24 hr time period were slightly higher inetabolism 12, 496–508, November 3, 2010 ª2010 Elsevier Inc. 497
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Role of TIF2 and SRC-1 in Skeletal MusclesTIF2(i)skm/ mice than in control mice, they did not reach statis-
tical significance (Figure S1G).
Oxygen consumption (VO2) was determined to characterize
energy expenditure. At 18 and 30 weeks of age, VO2 was 8%
and 18% higher in TIF2(i)skm/ mice than in control mice,
respectively (Figure 1D). At 18 weeks, CO2 production (VCO2)
was also 8% higher in TIF2(i)skm/ mice than in control mice,
resulting in a similar respiratory quotient (RQ, VCO2/VO2 ratio)
in mutant and control mice (Figures 1D and 1E). Interestingly,
VO2 decreased by 12.5% between 18 and 30 weeks in control
mice, leading to an increased RQ (Figures 1D and 1E), thus
demonstrating a shift in energy fuel consumption from fatty
acid to carbohydrate usage. In contrast, RQ was similar at 18
and 30 weeks in TIF2(i)skm/ mice, indicating the protection of
TIF2(i)skm/ mice from such an energy substrate shift. Calori-
metric parameters deduced from these analyses indicated that
heat production was increased by9% to12% in TIF2(i)skm/
mice at 18 and 30 weeks, respectively (Figure 1F). In agreement
with these results, body temperature was 1C higher in 14- to
30-week-old TIF2(i)skm/ mice than in age-matched control
mice (Figure 1G), further supporting the role of TIF2 in energy
expenditure.
Coupling between oxygen consumption and ADP phosphory-
lation occurs via an electrochemical proton gradient across the
inner mitochondrial membrane. Part of heat production results
from proton leak through this membrane, which uncouples
oxygen reduction from ATP synthesis. To test the implication
of TIF2 in muscle mitochondrial function, we determined oxygen
consumption in saponin-skinned quadriceps fibers from 14- and
30-week-old regular-diet-fed mice in the presence of the mito-
chondrial substrates glutamate and malate but in the absence
of ADP (V0). In TIF2
(i)skm/ mice, Vo was 10% and 12%
higher than in control mice at 14 and 30 weeks, respectively
(Figure 1H), thus demonstrating a higher proton leakage in skel-
etal muscle myocytes of TIF2(i)skm/ mice.
Maximal rate of O2 consumption (VMAX), determined after
exogenous ADP addition, was similar in TIF2(i)skm/ and control
mice at 14 weeks. However, while it was 7.5% lower at
30 weeks than at 14 weeks in control mice, it remained
unchanged in TIF2(i)skm/mice (Figure 1H). Thus, mitochondrial
activity decreased with time in control, but not in TIF2(i)skm/
mice. Moreover, oxidative phosphorylation efficiency, known
as the acceptor control ratio (ACR) defined by the ratio between
VMAX and V0, was 10% and 13% lower in TIF2(i)skm/ mice
than in control mice at 14 and 30 weeks, respectively
(Figure 1H), showing that uncoupling of oxidative phosphoryla-
tion was higher in skeletal muscles of TIF2(i)skm/ mice.
Taken together, the above results demonstrate that ablation of
TIF2 in myofibers of adult mice increases energy expenditure
through enhanced skeletal muscle mitochondrial uncoupling.
Uncoupling protein 1 (UCP1), which is selectively expressed in
brown adipose tissue in rodents, catalyzes a back flux of protons
not related to ATP synthesis to produce heat (Matthias
et al., 1999; Monemdjou et al., 1999). UCP1 transcript levels
were similar in brown adipose tissue of TIF2(i)skm/ and control
mice and were undetectable in their skeletal muscles (Figure 1I).
However, whereas at 11 weeks of age the transcript levels of the
two UCP1 homologs UCP2 and UCP3 were similarly expressed
in gastrocnemius of TIF2(i)skm/ and control mice, from 14 to498 Cell Metabolism 12, 496–508, November 3, 2010 ª2010 Elsevier30 weeks of age they were 2-fold higher in TIF2(i)skm/ mice
(Figure 1I), and UCP3 protein levels were increased by 2-fold
(Figure 1J).
AMP-activated protein kinase (AMPK) is a metabolic sensor
that becomes phosphorylated when the ATP/AMP ratio is low
(Hardie, 2007), such as during endurance exercise (Narkar
et al., 2008) and caloric restriction (Kondo et al., 2009). Phos-
pho-AMPK, by phosphorylating and inhibiting the activity of
the mitochondrial enzyme acetyl CoA carboxylase (ACC),
reduces malonyl-CoA production, thus leading to derepression
of mCPT1 activity and promotion of long-chain fatty acid (FA)
entry into the mitochondria and fatty acid oxidation to protect
cells from energy deprivation (Hoehn et al., 2010; Viollet et al.,
2009). To determine whether increased mitochondrial uncou-
pling in skeletal muscles of TIF2(i)skm/ mice might induce
AMPK activation, we determined the phospho-AMPK/total
AMPK ratio in gastrocnemius muscles by western-blot analysis.
This ratio was10-fold higher in TIF2(i)skm/mice than in control
mice from 14 to 30 weeks of age (Figure 1J and data not shown),
indicating that ATP levels were limiting in skeletal muscles of
TIF2(i)skm/mice. As ACCwas hyperphosphorylated in gastroc-
nemiusmuscle of 14- and 30-week-old TIF2(i)skm/mice, AMPK
activation contributes to the maintenance of mitochondrial fatty
acid oxidation in skeletal muscles of TIF2(i)skm/mice. Note that
even though phospho-AMPK has been shown to inhibit protein
synthesis via mTOR signaling in some conditions (Viollet et al.,
2009), it is unlikely that protein synthesis is impaired in skeletal
muscles of TIF2(i)skm/ mice as the phosphorylation level of
the mTOR target 4E-BP1 was similar in skeletal muscles of
control and mutant mice (Figure 1J) and as their skeletal muscle
weight and fiber size were similar (see above).
Taken together, these results demonstrate that TIF2 contrib-
utes to optimization of energy production in myofibers through
oxidative phosphorylation by increasing mitochondrial coupling.
TIF2(i)skm–/– Mice Are Protected from Fiber Type
Switching toward Lower Oxidative Capacity
Induced by Sedentariness
Mice express four myosin isoforms (MyHC1, 2A, 2X, and 2B)
in their skeletal muscles (Schiaffino, 2010). At 14 weeks of
age, muscle fiber type composition was similar in control and
TIF2(i)skm/ mice. Soleus was composed of about half slow-
MyHC1 and half MyHC2A fibers, whereas gastrocnemius con-
tained mainly MyHC2 fibers (Figure 2A). In soleus muscle of
control mice, the percentage of MyHC1 fibers decreased by
10% between 14 and 30 weeks of age and that of MyHC2A
concomitantly increased. At 18 and 30 weeks, 10% and 20%
of fibers coexpressed MyHC1 and MyHC2A, respectively, and
5% and 10% of the fibers expressed MyHC2X, respectively
(Figure 2A and data not shown). Strikingly, during this time
period, no fiber type switching was observed in soleus muscle
of mutant mice (Figure 2A and data not shown). Thus, MyHC1
fibers in soleus muscle of mutant mice were protected from
switching to MyHC2A fibers. Moreover, whereas the number of
fibers expressing MyHC1 protein decreased with aging in
gastrocnemius of control mice to represent less than 1% at
18 to 30 weeks, those expressing MyHC2A increased between
14 and 18 weeks from 15% to 40% and decreased to 1%
at 30 weeks (Figure 2A). From 18 to 30 weeks, the number ofInc.
Figure 2. TIF2(i)skm–/– Mice Are Protected from Age-Dependent Fiber Type Switching
(A) Representative MyHC1 (I), MyHC2A (A), and MyHC2B (B) immunohistochemical detection (brown) on serial sections of soleus and quadriceps from 14-, 18-,
and 30-week-old control and TIF2(i)skm/ mice. Fibers coexpressing MyHC1 and MyHC2A are labeled I/A. Fibers that are negative for MyHC1, MyHC2A, and
MyHC2B correspond to MyHC2X fibers (X); the scale bar represents 50 mm.
(B) Histochemical staining of NADH dehydrogenase and succinate dehydrogenase activities in tibialis muscle of 14- and 30-week-old control and TIF2(i)skm/
mice. Three different fiber types are distinguished. Oxidative and intermediate fibers are darkly and moderately stained, respectively; glycolytic fibers are
unstained. The scale bar represents 200 mm.
(C) Relative transcript levels in gastrocnemius muscle of 11-, 14-, 18-, and 30-week-old control and TIF2(i)skm/ mice of mitochondrial electron transport chain
genes (complex I: Ndufb3; complex II: Sdhd; complex III: Uqcrc1; complex IV: Cox5b; complex V: Atp5i) of nuclear respiratory factor 1 (NRF-1) and of mitochon-
drial transcription factor A (TFAM).
(D) Oxygen consumption in saponin-skinned quadriceps fibers of 14- and 30-week-old control and TIF2(i)skm/ mice in presence of palmitoyl-L-carnitine
(VPalm-Carn).
(A and B) n = 6; (C and D) n = 10. Error bars in (C and D) show SEM. *p < 0.05. See also Figure S2.
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Role of TIF2 and SRC-1 in Skeletal Musclesfibers expressing MyHC2B increased from 40% to 95%,
showing a progressive fiber type switching from 1 to 2A, and
from 2A to 2B, via 2X, in agreement with previous reports (Schiaf-
fino, 2010 and references therein). In contrast, in gastrocnemiusCell Mof mutant mice, the percentage of MyHC1 and MyHC2A fibers
decreased only after 18 weeks of age, to reach 1% and 6% at
30 weeks of age, respectively, and that of MyHC2B fibers
increased during this time period to reach about 90% at weeketabolism 12, 496–508, November 3, 2010 ª2010 Elsevier Inc. 499
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Role of TIF2 and SRC-1 in Skeletal Muscles30 (Figure 2A). In agreement with these results, switching of slow
to fast fibers was also retarded in quadriceps muscle of mutant
mice (Figure S2A).
Histochemical staining of the reduced form of nicotinamide
adenine dinucleotide (NADH) dehydrogenase (mitochondrial
respiratory complex I) and succinate dehydrogenase (complex
II) activities in tibialis muscle showed that the proportion of darkly
stained oxidative fibers decreased in control mice from 14 to
30 weeks (Figure 2B and data not shown). In contrast, similar
activities were observed in 14- to 30-week-old TIF2(i)skm/
mice. Moreover, transcript levels of genes encoding subunits
of the mitochondrial respiratory chain (such as NADH dehydro-
genase ubiquinone 1 beta subcomplex 3 [Ndufb3; complex I];
succinate dehydrogenase complex, subunit B [Sdhb; complex
II]; ubiquinol-cytochrome c reductase core protein I [Uqcrc1;
complex III]; cytochrome c oxidase subunit Vb [Cox5b; complex
IV]; and ATP synthase, H+ transporting, mitochondrial F0
complex, subunit e [Atp5i; complex V]), as well as those of the
nuclear respiratory factor-1 (NRF-1, an oxidative gene control-
ling transcription factor) and of the mitochondrial transcription
factor A (TFAM, a factor controlling mitochondrial transcription
and replication), decreased less between 11 and 30 weeks in
gastrocnemius of TIF2(i)skm/ mice than in that of control mice
(Figure 2C).
As O2 consumed by saponin-skinned quadriceps myofibers in
presence of the substrate palmitoyl-L-carnitine was reduced by
20% from 14 to 30 weeks in control but not in TIF2(i)skm/ mice
(Figure 2D), fatty acid oxidative capacity was maintained in
quadriceps of mutant but not of control mice. The transcript
levels of genes controlling lipolysis (lipoprotein lipase, LPL), fatty
acid uptake (fatty acid translocase, FAT/CD36), binding (heart
fatty-acid binding protein, hFABP), activation (long-chain
acyl-CoA synthetase, LCAS), b-oxidation (b-hydroxy-acyl-CoA
dehydrogenase, b-HAD, and long-, medium- and short-chain
acyl-CoA dehydrogenase, LCAD, MCAD, and SCAD, respec-
tively), and tricarboxylic acid (TCA) cycle (citrate synthase, CS)
decreased less between 11 and 30 weeks in gastrocnemius of
TIF2(i)skm/ mice than in that of control mice (Figure 3A).
Remarkably, the transcript level of the muscle carnitine palmi-
toyltranferase 1 (mCPT1), encoding an enzyme that catalyzes
the rate-controlling step of fatty acid oxidation, increased in
aging TIF2(i)skm/ mice but not in control mice (Figure 3A).
Note that the transcript levels of the glycolytic enzyme phospho-
fructokinase (PFK) and the activity of the glycolytic enzyme
lactate dehydrogenase (LDH) were similar in gastrocnemius of
11- to 30-week-old control and mutant mice (Figure 3B and
Figure S2B).
The transcript levels of PGC-1a, a transcriptional coregulator
known to control mitochondrial biogenesis and slow fiber type
maintenance in skeletal muscle (Arany, 2008; Choi et al., 2008;
Wenz et al., 2008), were stable in gastrocnemius of control
mice between 14 and 30 weeks, but progressively increased in
TIF2(i)skm/ mice, resulting in 2.5-fold higher levels at 30 than
at 11 weeks (Figure 3A). In contrast, no significant difference in
transcript levels of PGC-1b, a homolog of PGC-1a, was
observed (Figure S2C). It is of note that sedentary-lifestyle-
induced decreased muscle oxidative capacity was not associ-
ated with decreased mitochondrial number, as mitochondrial
DNA content and aconitase protein levels were similar in quadri-500 Cell Metabolism 12, 496–508, November 3, 2010 ª2010 Elsevierceps of control mice at 14 to 30 weeks (Figures 3C and 3D).
Moreover, whereas mitochondrial content was similar in 14- to
18-week-old control and mutant mice, it increased in skeletal
muscles of TIF2(i)skm/ mice after 18 weeks of age (Figures 3C
and 3D). Ultrastructural analyses performed at 30 weeks demon-
strated that both muscle mitochondrial content and size were
higher in tibialis of mutant than of control mice (Figure 3E and
Figures S2D and S2E).
Even thoughmutantmicewere partially protected from seden-
tariness-induced slow to fast fiber type switching, and main-
tained higher muscle oxidative capacities than control mice,
18-week-old TIF2(i)skm/ mice were less effective at endurance
running than age-matched control mice (Figure S2F). Note,
however, that muscle strength determined by grip test was
similar in 11- to 18-week-old control and TIF2(i)skm/ mice
(Figure S2G).
TIF2(i)skm–/– Mice Are Protected from Type 2 Diabetes
and High-Fat-Diet-Induced Obesity
When fed a chow diet, blood cholesterol, triglyceride, and free
fatty acid levels were similar in control and TIF2(i)skm/ mice
(Figure S3A). Serum glucose levels were also similar in control
and TIF2(i)skm/ mice from 8 to 17 weeks (Figure 4A and data
not shown). However, while those of control mice progressively
rose from 165 mg/dl at 14 weeks to 268 mg/dl at 30 weeks,
those of mutant mice only reached 228 mg/dl at 30 weeks
of age (Figure 4A and data not shown). At 18 weeks, insulin
levels were 25% lower in TIF2(i)skm/ mice than in control
mice (Figure 4B). Mutant mice were slightly more insulin
sensitive than control mice (Figure 4C), and their glucose uptake
was higher when subjected to an intraperitoneal glucose toler-
ance test (Figure 4D). At 30 weeks, control mice remained less
glucose tolerant than TIF2(i)skm/ mice (Figure 4D) and were
much more insulin-resistant than mutant mice (Figure 4C).
Note that at this age, serum levels of insulin were also lower
in TIF2(i)skm/ mice than in control mice (Figure 4B). Thus,
sedentary TIF2(i)skm/ mice are partially protected from type 2
diabetes.
When challenged with a high-fat diet (HFD), TIF2(i)skm/ mice
gained 5.5% and 17% less weight than controls from week 8 to
12 and from week 8 to 23, respectively (Figure 4E), despite
similar food intake (Figure S3B). DEXA scan analyses revealed
that body fat content was 42% lower in TIF2(i)skm/ mice than
in control mice at 23 weeks of age (Figure 4F). In agreement
with these results, epididymal fat mass was lower in 23-week-
old TIF2(i)skm/ mice than in control mice (Figure S3C), and
histological analyses revealed that their adipocytes were less
hypertrophic (Figure 4G and Figure S3D). High-fat-diet feeding
induced liver and muscle steatosis as well as a reduction of
muscle mass in control mice, in agreement with previous reports
(Almond and Enser, 1984; Lillioja et al., 1987), but not in mutant
mice (Figures S3E–S3G). Blood glucose levels increased less in
mutant than in control mice upon high-caloric-diet feeding, and
at 25 weeks blood cholesterol and triglyceride levels were lower
in TIF2(i)skm/ mice than in control mice (Figures S3H and S3I),
and insulin sensitivity was improved in mutant mice (Fig-
ure S3J). Moreover, transcript levels of UCP2, UCP3, and
PGC-1a, as well as those encoding enzymes involved in lipolysis
(LPL); in fatty acid uptake (FAT/CD36), binding (hFABP), andInc.
Figure 3. Analysis of Transcript Levels of Genes Controlling Muscle Oxidative Capacities and Determination of Mitochondrial Content
(A) Relative transcript levels in gastrocnemius muscle of 11-, 14-, 18-, and 30-week-old control and TIF2(i)skm/mice of LPL, FAT/CD36, hFABP, LCAS, b-HAD,
LCAD, MCAD, SCAD, mCPT1, CS, and PGC-1a.
(B) Biochemical determination of LDH activity in tibialis extracts of 11-, 18-, and 30-week-old control and TIF2(i)skm/mice and in soleus extracts of 30-week-old
control and TIF2(i)skm/ mice.
(C) Quantification of mitochondrial content in quadriceps of 14-, 18-, and 30-week-old control and TIF2(i)skm/mice by PCR amplification of theCox2mitochon-
drial gene and the FAS nuclear gene.
(D)Western-blot analysis of themitochondrial protein aconitase in quadricepsmuscle of 14-, 18-, and 30-week-old control and TIF2(i)skm/mice. GAPDH is used
as an internal control.
(E) Mitochondria number and mean mitochondria cross sectional area in tibialis muscles from 30-week-old control and TIF2(i)skm/ mice evaluated by electron
microscopy.
(A–C) n = 10; (D) n = 6; and (E) n = 4. Error bars in (A–C) and (E) show SEM. *p < 0.05.
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Role of TIF2 and SRC-1 in Skeletal Musclesactivation (LCAS); and in b-oxidation (b-HAD and SCAD), were
higher in TIF2(i)skm/ mice than in control mice after 15 weeks
of high-fat-diet feeding (Figure S3K). Thus, increased energy
expenditure through enhanced skeletal muscle mitochondrial
uncoupling in TIF2(i)skm/ mice improved their metabolic profile
when fed a high-caloric diet, attenuated obesity and diabetes,
and protected them from muscle wasting.Cell MEnhanced Energy Expenditure in Myofibers
of TIF2(i)skm–/– Mice Is SRC-1 Dependent
Previous results have shown that the relative amounts of TIF2
and SRC-1 modify the transcriptional control in white and brown
adipose tissues (Picard et al., 2002). Interestingly, transcript
and protein levels of SRC-1 were higher in skeletal muscle of
TIF2(i)skm/ than of control mice at 11 weeks, whereas thoseetabolism 12, 496–508, November 3, 2010 ª2010 Elsevier Inc. 501
Figure 4. Lack of TIF2 in Skeletal Muscle Partially Protects from Obesity and Type 2 Diabetes
(A) Serum glucose levels in 11-, 14-, 18-, and 30-week-old control and TIF2(i)skm/ mice.
(B–D) Serum insulin levels (B), intraperitoneal insulin sensitive test (IPIST) (C), and intraperitoneal glucose tolerance test (IPGTT) (D) in 18- and 30-week-old control
and TIF2(i)skm/ mice.
(E) Body weight of control and TIF2(i)skm/ mice fed a high-fat diet.
(F) Body fat content in 23-week-old control and TIF2(i)skm/ mice fed a high-fat diet evaluated by DEXA scanning.
(G) Representative hematoxylin and eosin stained epididymal fat pad of 23-week-old control and TIF2(i)skm/ mice fed a high-fat diet.
(A–D) n = 10, chow diet; (E–G) n = 12, high-fat diet. Error bars in (A–F) show SEM. *p < 0.05. See also Figure S3.
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Role of TIF2 and SRC-1 in Skeletal Musclesof UCP3 were increased in mutant mice only after 14 weeks of
age (Figures 5A and 5B and Figure S4A). UCP2 and PGC-1a
transcript levels were also increased in skeletal muscles of
TIF2(i)skm/ mice but at a later time point than the levels of
SRC-1 (Figure 5A). In contrast, transcript levels of SRC-3 were
similar in skeletal muscles of TIF2(i)skm/ and control mice
(Figure 5A). Thus, these data suggest that the balance between
TIF2 and SRC-1 levels might play a crucial role in the control of
UCP2, UCP3, and/or PGC-1a expression in skeletal muscle
myofibers.
To further characterize gene transcriptional control by TIF2
and SRC-1, we performed transient transfection assays in differ-
entiated C2C12 myocytes. Whereas SRC-1 overexpression
stimulated UCP3 expression up to 3.5-fold in a dose-dependent
manner (Figure 5C), TIF2 overexpression repressed its expres-
sion by up to 30% (Figure 5C). Moreover, even though SRC-1
or TIF2 overexpression did not affect each other’s protein levels
(Figure S4B and data not shown), TIF2 overexpression502 Cell Metabolism 12, 496–508, November 3, 2010 ª2010 Elsevierdecreased SRC-1-stimulated UCP3 expression (Figure 5C and
Figure S4B), indicating that these coregulators have antagonistic
activities on UCP3 transcription.
In agreement with previous reports (Dressel et al., 2003), treat-
ment of mouse C2C12 myocytes with the PPARb-selective
agonist GW501516 induced UCP3 transcript levels by more
than 8-fold (Figure 5D). Sequence alignments of the promoter
region of the human UCP3 gene, which encompasses two
PPAR response elements (PPREs) (Acı´n et al., 1999; Tu et al.,
2000), showed that the promoter of the mouse UCP3 gene
contains such elements at position 234 to 222 and 56
to 34 relative to its transcriptional start site (Figure 5E). Chro-
matin immunoprecipitation (ChIP) from C2C12 myocytes with
antibodies directed against SRC-1 or TIF2 did not reveal the
presence of SRC-1 or TIF2-containing complexes on DNA
segments encompassing these PPREs (Figure 5F). In the pres-
ence of GW501516, endogenous SRC-1, but not TIF2, was
recruited to the PPRE-containing DNA segments of UCP3Inc.
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Role of TIF2 and SRC-1 in Skeletal Muscles(Figure 5F). Moreover, overexpressed SRC-1 was recruited to
these DNA segments in the absence of ligand treatment, and
GW501516 further promoted SRC-1 recruitment to these DNA
segments and increased UCP3 transcript levels (Figures 5D
and 5G). As the fold increase of UCP3 transcript levels in
response to GW501516 was similar with and without SRC-1
overexpression, SRC-1 might coactivate PPARb and/or other
enhancer factors bound to the UCP3 promoter. In contrast,
even though overexpressed TIF2 was efficiently recruited to
PPRE-containing DNA segments of UCP3 in the absence of
ligand treatment, GW501516 strongly decreased its recruitment
to these DNA segments and relieved its repressive action on
UCP3 transcription (Figures 5D and 5H). Thus, whereas overex-
pressed TIF2 interacts with enhancer factors bound to the UCP3
promoter under basal conditions, PPARb ligands impair this
association and promote that of SRC-1.
SRC-1 overexpression in differentiated C2C12 myocytes also
enhanced PGC-1a expression, as well as that of PGC-1a target
genes (e.g., LPL and mCPT1 [Lagouge et al., 2006; Lin et al.,
2002; Vega et al., 2000]), in a dose-dependent manner (Figures
S4B and S4C). Note that the levels of phosphorylated AMPK and
ACC were not enhanced in these conditions (Figure S4B), indi-
cating that short term SRC-1 overexpression is not sufficient to
induce energy deprivation in C2C12myocytes. TIF2 overexpres-
sion decreased PGC-1a, LPL, and mCPT1 transcript levels in
a dose-dependent manner (Figure S4D).
Taken together, these results show that SRC-1 and TIF2 are
involved in the transcriptional control of UCP3 and PGC-1a in
differentiated C2C12 myocytes and that the balance between
their levels is crucial for fine tuning the expression of these target
genes. As SRC-1 and TIF2 recruitment to PPRE-containing
DNA segments of UCP3 were strongly modulated by PPARb
ligand, it is likely that these coregulators control PPARb activity
in myocytes.
To determinewhether SRC-1 overexpression was involved the
defects induced by TIF2 ablation in muscle myofibers, we gener-
ated TIF2/SRC-1(i)skm/mice in which both TIF2 and SRC-1 are
selectively ablated in skeletal muscle myofibers (see Supple-
mental Results and Figure S5).
In contrast to TIF2(i)skm/ mice, UCP2 and UCP3 transcript
levels were not increased in gastrocnemius of 20- to 30-week-
old TIF2/SRC-1(i)skm/ mice (Figure 5I and data not shown),
and their body temperature was similar to that of age-matched
control mice (Figure S4E). AMPK was not activated in their skel-
etal muscles, and the transcript levels of PGC-1a and of genes
encoding enzymes controlling fatty acid metabolism and
subunits of the mitochondrial respiratory chain were not
enhanced (Figures 5I and 5J and Figure S4F). Moreover, mito-
chondrial complex 2 activity similarly decreased in tibialis of
TIF2/SRC-1(i)skm/ and control mice between 14 and 20 weeks
of age (Figure S4G and data not shown), and no difference in
body weight and blood glucose levels were observed between
TIF2/SRC-1(i)skm/ mice and control littermates when fed
a regular or a high-fat diet (Figures S4H–S4J and data not
shown). Thus, enhanced thermogenesis and oxidative metabo-
lism in TIF2-deficient myofibers were blunted in mice lacking
both TIF2 and SRC-1 in these cells. Note that the selective
lack of SRC-1 in skeletal muscle myofibers induced no major
defects (see Supplemental Information).Cell MDISCUSSION
Previous studies of TIF2 null mice had shown that TIF2 promotes
fasting hepatic glucose release and lipid storage in white
adipose tissue and negatively regulates adaptive thermogenesis
in brown adipose tissue (Chopra et al., 2008; Picard et al., 2002).
These effects were mainly attributed to the regulation by TIF2 of
glucose-6 phosphatase expression in hepatocytes by acting as
a coactivator of the orphan nuclear receptor RORa, to themodu-
lation of PPARg-mediated fat uptake and storage pathways in
white adipocytes, and to a competitionwith SRC-1 for the forma-
tion of PGC-1a/PPARg complexes in brown adipocytes.
We have shown in this study that TIF2 has also a major meta-
bolic role in skeletal muscles. Indeed, selective ablation of TIF2 in
skeletal muscle myofibers of adult mice resulted in increased
energy expenditure through enhancedmitochondrial uncoupling
in these cells. When fed a regular diet, food intake was raised in
TIF2(i)skm/ mutant mice to meet the energetic requirements of
their skeletal muscles and to maintain their body weight. More-
over, increased energy expenditure partially protected these
mice against high-caloric-diet-induced obesity (Figure 6). Thus,
TIF2 appears to coordinate energymetabolism in various tissues
by promoting energy storage in white adipocytes, by limiting
energy dissipation in brown adipocytes and skeletal muscles in
fed conditions, and by favoring hepatic glucose release upon
fasting.
Our data show that the levels of UCP3 were about 2-fold
increased in skeletal muscle myocytes of TIF2(i)skm/ mice,
and several studies have reported that overexpression of this
protein in skeletal muscle myocytes enhances mitochondrial
uncoupling and muscle heat production and reduces body
weight gain upon high-fat-diet feeding (Clapham et al., 2000;
Son et al., 2004; Tiraby et al., 2007). Thus, increased mitochon-
drial uncoupling in TIF2(i)skm/micemight result, at least in part,
from elevated UCP3 levels. Note that UCP2 overexpression in
skeletal muscles of TIF2(i)skm/ mice might also contribute to
increased thermogenesis (Schrauwen and Hesselink, 2002).
However, if, as indicated by other studies (Bezaire et al., 2005;
Cadenas et al., 2002), UCP3 and UCP2 do not induce mitochon-
drial uncoupling, TIF2 might negatively regulate the expression
of an as yet unidentified uncoupling protein in skeletal muscles.
In any event, our results show that TIF2 limits proton leakage in
myocytes, thereby optimizing the coupling between oxidation
and phosphorylation in skeletal muscles.
As UCP3 expression is stimulated by various nuclear recep-
tors that interact with p160 coregulators, including PPARb
(Acı´n et al., 1999; Gong et al., 1997; Solanes et al., 2003), TIF2
might repress the activity of these receptors in skeletal muscle
myofibers. Our ChIP experiments performed in differentiated
C2C12 myocytes did not, however, reveal the presence of
endogenous TIF2 on DNA segments encompassing PPREs
located in the UCP3 promoter region in the absence or presence
of PPARb ligand. Moreover, while TIF2 levels were strongly
decreased within 1 week after TIF2 gene ablation, the transcript
levels of UCP3, as well as of UCP2 and PGC-1a, were enhanced
only more than 1 month later, thus indicating that endogenous
TIF2 might not repress the expression of these genes under
basal conditions. Interestingly, we found that SRC-1 levels
were increased at an early time after TIF2 ablation, thus stronglyetabolism 12, 496–508, November 3, 2010 ª2010 Elsevier Inc. 503
Figure 5. Transcriptional Control by TIF2 and SRC-1
(A) Relative transcript levels of TIF2, SRC-1, SRC-3, UCP2, UCP3, and PGC-1a in gastrocnemius muscle of 8-, 10-, 11-, 14-, and 30-week-old control and
TIF2(i)skm/ mice.
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Figure 6. Schematic Illustration of the Puta-
tive Role of TIF2 in Skeletal Muscles
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Role of TIF2 and SRC-1 in Skeletal Musclessuggesting that enhanced SRC-1 levels might stimulate UCP3
expression. This assumption was strengthened in differentiated
C2C12 cells, where SRC-1 overexpression promoted SRC-1
binding to PPRE-containing DNA segments of UCP3 and
enhanced the expression of this gene. Moreover, even though
UCP3 transcript levels were unchanged in SRC-1 myofiber-defi-
cient mice, enhanced UCP3 levels in TIF2-depleted myofibers
were SRC-1 dependent. Thus, these data indicate that endoge-
nous levels of SRC-1 and TIF2 exert little if any control on UCP3
transcription under basal conditions, whereas SRC-1 overex-
pression enhances UCP3 expression. Note that our data in
differentiated C2C12 myocytes also show that overexpressed
TIF2 counteracts SRC-1-induced UCP3 expression in the
absence of PPARb ligand but does not inhibit PPARb ligand-
induced UCP3 expression. Thus, depending on its levels and
the presence of PPARb ligand, TIF2 either does not modulate
UCP3 expression or acts as a transcriptional corepressor,
whereas SRC-1 stimulates UCP3 expression, most likely by
coactivating PPARb.
As most metabolic defects induced by selective ablation of
TIF2 in skeletal muscle fibers were SRC1 dependent, and as
UCP3 overexpression in skeletal muscles of mice generated
defects that are similar to those of TIF2(i)skm/ mice (Clapham
et al., 2000; Son et al., 2004; Tiraby et al., 2007), our data strongly
suggest that TIF2 controls important muscle functions by main-
taining low SRC-1 levels and thereby limits UCP3 expression
and mitochondrial uncoupling in skeletal muscle myofibers.(B) Western-blot analysis of SRC-1 and UCP3 proteins in quadriceps muscle of 11-, 14-, and 30-week-old c
used as an internal control.
(C) Relative UCP3 transcript levels in C2C12 myocytes transiently transfected with 100 ng or 1 mg SRC-1 an
(D) Relative UCP3 transcript levels in C2C12 cells transiently transfected with SRC-1 and/or TIF2 expression v
of GW501516 (GW). *p% 0.05 between  and + GW; xp% 0.05 between untransfected and SRC-1 or TIF2
(E) Sequence of a consensus PPRE and of the two human (h) and mouse (m) UCP3 PPREs (PPRE1 and PP
(F–H) PCR detection of the DNA segments encompassing theUCP3-PPREs and of a DNA segment downstrea
chromatin immunoprecipitation from C2C12myocytes grown in the absence (GW) or presence (+GW) of GW
TIF2 or with normal rabbit serum (NRS). C2C12 myocytes were transfected with empty vector (control) (G a
expression vector (1 mg) (H). Data are expressed as a percentage relative to the input DNA.
(I) Relative UCP2, UCP3, and PGC-1a transcript levels in gastrocnemiusmuscle of 30-week-old TIF2(i)skm/, T
their respective controls (TIF2L2/L2, TIF2/SRC-1L2/L2, and SRC-1L3/L3).
(J) Representative western-blot analysis of pAMPK and total AMPK (AMPK) in quadriceps muscle of 14- and
SRC-1(i)skm/mice and of their respective controls. GAPDH is used as an internal control. (A and I) n = 10; (B–
SEM. *p < 0.05. See also Figure S4.
Cell Metabolism 12, 496–508,Our data also show that TIF2 and SRC-1
have the opposite effects on other genes
(e.g., PGC-1a), indicating that these
coregulators fine tune the levels of a
number of proteins to coordinate meta-
bolic pathways. Whether the levels of
TIF2 and SRC-1 are modified in patho-
physiological conditions in skeletal mus-
cle myofibers, and how TIF2 controls
SRC-1 levels, remains to be determined.
In agreement with previous studies
(Figueiredo et al., 2009; Zoll et al., 2002;Schiaffino, 2010 and references therein), our data show that
skeletal muscle contractile andmetabolic properties are strongly
affected in sedentary mice. Indeed, oxidative capacities of con-
trol mice progressively decreased from 11 to 30 weeks, and this
decrease was associated with a slow to fast fiber type switching.
The cause of these changes are unknown, but oxidative stress
and mitochondrial damage could play a major role (Figueiredo
et al., 2009; Short et al., 2005).
Interestingly, muscle oxidative and contractile properties were
maintained in TIF2(i)skm/ mice during this time period, and, in
contrast to wild-type mice, mutant mice were partially protected
against type 2 diabetes (Figure 6). The fuel gauge AMPK,which is
stimulated by caloric restriction as well as by endurance exercise
to enhance muscle oxidative metabolism, was constitutively
activated in skeletal muscles of sedentary TIF2(i)skm/ mice,
demonstrating that their skeletal muscles were in a chronic
low-energy state.
In agreement with previous work (Ja¨ger et al., 2007) showing
that activated AMPK induces the expression of PGC-1a, a key
factor for stimulation of mitochondrial oxidative metabolism,
PGC-1a transcript levels progressively increased in skeletal
muscles of TIF2(i)skm/ mice. Note that increased SRC-1 levels
in TIF2(i)skm/ myofibers might also contribute to enhanced
PGC-1a levels. Moreover, enhanced PGC-1a activity by acti-
vated-AMPK phosphorylation (Ja¨ger et al., 2007) and AMPK-
dependent SIRT1-mediated deacetylation (Canto´ and Auwerx,
2009) might further stimulate oxidative phosphorylation inontrol (CT) and TIF2(i)skm/ mice (TIF2). GAPDH is
d/or TIF2 expression vectors.
ectors (1 mg) and grown in the absence or presence
transfected cells.
RE2).
m of theUCP3 transcriptional start site (I3/E4) after
501516 with antibodies directed against SRC-1 or
nd H), SRC-1 expression vector (1 mg) (G), or TIF2
IF2/SRC-1(i)skm/, and SRC-1(i)skm/mice and of
30-week-old TIF2(i)skm/, TIF2/SRC-1(i)skm/, and
D, F–H, and J) n = 6. Error bars in (A, C, D, F–I) show
November 3, 2010 ª2010 Elsevier Inc. 505
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Role of TIF2 and SRC-1 in Skeletal MusclesTIF2(i)skm/ skeletal muscle myofibers. Indeed, PGC-1a, by
coactivating numerous transcription factors, stimulates its own
expression, that of UCP2 and UCP3, as well as that of a number
of factors controlling the formation and maintenance of slow-
oxidative fibers (Arany, 2008; Puigserver et al., 2001; Rohas
et al., 2007; St-Pierre et al., 2003; Wu et al., 1999). Thus, TIF2
deficiency, by enhancing SRC-1 levels, most likely induces
a feed-forward loop that promotes uncoupling and oxidative
metabolism (Figure 6). Enhanced expression of the enzyme
mCPT-1, which catalyzes the rate-limiting step in the pathway
of mitochondrial fatty acid oxidation and is induced by increased
levels of PGC-1a (Zhang et al., 2004) and/or of SRC-1 (see
above), combined with derepression of its activity by phosphor-
ylated AMPK (Hoehn et al., 2010; Viollet et al., 2009), might be
a key event in stimulation of skeletal muscle oxidative metabo-
lism in TIF2(i)skm/ mice. It is of note that the increased
mitochondrial activity was sufficient to meet the energetic
requirements of skeletal muscles in TIF2(i)skm/ mice for more
than 2months under sedentary conditions, but not during endur-
ance exercise, and thatmitochondrial biogenesis was stimulated
at a later time only.
To conclude, the current study demonstrates that TIF2 limits
mitochondrial uncoupling to optimize ATP production during
oxidative phosphorylation in skeletal muscles, mainly by main-
taining low SRC-1 levels in myofibers. Thus, it has highly benefi-
cial effects in mammals living in the wilderness, where food
supply is limiting and energy demands are high. In contrast,
under sedentary conditions and food excess, two characteristics
of industrialized societies, TIF2-induced optimized energy
production in skeletal muscle myocytes promotes a slow/
oxidative to fast/glycolytic fiber type switching, leading to type
2 diabetes and the development of obesity, and thus becomes
detrimental for health (Figure 6). Lowering metabolic efficiency
by decreasing TIF2 activity or increasing SRC-1 activity in skel-
etal muscles represents an attractive strategy to counteract
Western-lifestyle-induced metabolic disorders, such as obesity
and diabetes, even though endurance exercise will be impaired.
EXPERIMENTAL PROCEDURES
Body Lean and Fat Content
Body lean and fat content were recorded in anaesthetized mice DEXA
(PIXIMUS, GEMedical Systems, Buc, France) according to themanufacturer’s
instructions.
Food Consumption
Mice were individually housed. Food pellets (150 g) were delivered and
weighed after 1 week. Weekly food consumption was calculated by subtract-
ing the final from the initial pellet weight.
Blood Glucose Level Analysis
Glucose levels were determined on a drop of blood collected from the tail vein
of fed mice with an Accu-Chek Active blood glucometer (Roche, France).
RNA Preparation and Analysis
RNA was isolated with TRIzol Reagent (Invitrogen). Five micrograms of RNA
was converted to cDNA with SuperScript II reverse transcriptase (Invitrogen,
Life Technologies) and dT24 primers according to the supplier’s protocol.
Quantitative RT-PCR was performed by using the QuantiTectTM SYBR Green
PCR kit (Roche) according to the supplier’s protocol. HPRT was used as an
internal control. Primer sequences are given in Table S1.506 Cell Metabolism 12, 496–508, November 3, 2010 ª2010 ElsevierData Analysis
Data are represented asmean ± standard error of the mean (SEM). Differences
analyzed by a two-tailed Student’s t tests were considered statistically signif-
icant at p% 0.05 and are indicated by an asterisk in the figures. In Figure 5, #
indicates p > 0.05.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Results, Supplemental
Experimental Procedures, five figures, and one table and can be found with
this article online at doi:10.1016/j.cmet.2010.09.016.
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